Clinical Trial Details of World's 1st Homeopathy COVID-19 Study

Homoeopathy as adjuvant in management of Covid-19 infection 


Type of Trial Interventional 
Type of Study  Homeopathy 
Study Design Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study  Homoeopathy as adjuvant in management of Covid-19 infection 
Scientific Title of Study  Effect of adjuvant homoeopathy with standard treatment protocol in management of covid-19: a randomised, open label, placebo controlled, parallel group study  

Details of Principal Investigator or overall Trial Coordinator (multi-center study) 
Name Prof Dr Pradeep Kumar Gupta 
Designation Principal 
Affiliation Naiminath Homoeopathic Medical College, Hospital and Research Centre 


Health Condition / Problems Studied  
Health Type Condition 
Patients B972||Coronavirus as the cause of diseases classified elsewhere,  


Intervention / Comparator Agent
Type Name Details 
Intervention Homoeopathic medicine Homoeopathic medicines will be given to this group patients as an add-on to standard treatment. Following Individualization medicines will be selected keeping in view pathological aspect of disease. Dose and potency will be according to the frequency, intensity and duration of signs and symptoms. Repetitions will vary from case to case basis considering disease state and vitality of patient. Range of potency from 30, 200, 1M etc will be used.  
Comparator Agent Placebo Placebo group patients will receive identical placebo (globules moistened with dispensing alcohol) as an add on to standard protocol treatment. Dose repetition will be a in similar pattern to medicine group. 

Inclusion Criteria
Age From 18.00 Year(s)
Age To 80.00 Year(s)
Gender Both 
Details o Symptomatic RT-PCR confirmed cases of
Covid-19 infection.
o Both sexes
o Age between 18 years to 80 years and
o Willing to give signed written informed
consent
 

ExclusionCriteria 
Details 1. Patients requiring ventilatory support
2. Patients with compromised immunity
3. Severe heart, lung, kidney, brain, blood
diseases or other important systemic
diseases
4. Subjects unable to complete the study, or
not suitable for the study by
researchers.
5. Women during pregnancy
6. Lactating mothers
 

Method of Generating Random Sequence  Computer generated randomization 

Primary Outcome  
Outcome TimePoints 
Clinical outcome in terms of recovery of patient or requirement of life support (ventilator)/ death. Ever 24 hr. 

Secondary Outcome  
Outcome TimePoints 
i. Time to progression to critical stage
ii. Time to fever clearance
iii. Time to resolution of pneumonia
iv. Change in severity of symptoms as per clinical syndromes associated with COVID - 19 infection.
v. Time to recovery in terms of 2 negative test for Covid-19
vi. Period of hospital stay
vii. Requirement of conventional medication till clinical improvement
 
Ever 24 hr. 

Target Sample Size  Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 

Brief Summary
 

The results of the study will be able to predict the role of add on homoeopathic treatment for management of Covid-19 infected. In the absence any known anti-viral and vaccine the positive results of this study will decrease the morality and morbidity due to this pandemic. Further the cost-effectiveness of homoeopathy will enable developing countries in controlling such deadly disease effectively.



Complete details of the clinical study


8 comments:

  1. Nice initiative, should help fruitful results. Thanks Team Homeopathy Health Heroes

    ReplyDelete
  2. May GOD HELP IN THIS RESEARCH STUDY / TREATMENT

    ReplyDelete
  3. Credit goes to team who are engaged in this research and finally got the result.

    ReplyDelete
  4. That's great, prayers and wishes

    ReplyDelete
  5. My wishes...The world needs a new face in treating the sick

    ReplyDelete
  6. Great, best wishes from France .Dr William Suerinck

    ReplyDelete
  7. In this stage, a person should develop awareness about addiction, build a social support system, and work on a deterioration prevention plan. clinica recuperação

    ReplyDelete